The MKID Exoplanet Camera for Subaru SCExAO

We present the MKID Exoplanet Camera (MEC), a z through J band (800 - 1400 nm) integral field spectrograph located behind The Subaru Coronagraphic Extreme Adaptive Optics (SCExAO) at the Subaru Telescope on Maunakea that utilizes Microwave Kinetic Inductance Detectors (MKIDs) as the enabling technology for high contrast imaging. MEC is the first permanently deployed near-infrared MKID instrument and is designed to operate both as an IFU, and as a focal plane wavefront sensor in a multi-kHz feedback loop with SCExAO. The read noise free, fast time domain information attainable by MKIDs allows for the direct probing of fast speckle fluctuations that currently limit the performance of most high contrast imaging systems on the ground and will help MEC achieve its ultimate goal of reaching contrasts of $10^{-7}$ at 2$\lambda / D$. Here we outline the instrument details of MEC including the hardware, firmware, and data reduction and analysis pipeline. We then discuss MEC's current on-sky performance and end with future upgrades and plans.Comment: To be published in Publications of the Astronomical Society of the Pacifi

MKID Exoplanet Camera for Subaru SCExAO

We present the MKID Exoplanet Camera (MEC), a z through J band (800–1400 nm) integral field spectrograph located behind The Subaru Coronagraphic Extreme Adaptive Optics (SCExAO) at the Subaru Telescope on Maunakea that utilizes Microwave Kinetic Inductance Detectors (MKIDs) as the enabling technology for high contrast imaging. MEC is the first permanently deployed near-infrared MKID instrument and is designed to operate both as an IFU, and as a focal plane wavefront sensor in a multi-kHz feedback loop with SCExAO. The read noise free, fast time domain information attainable by MKIDs allows for the direct probing of fast speckle fluctuations that currently limit the performance of most high contrast imaging systems on the ground and will help MEC achieve its ultimate goal of reaching contrasts of 10⁻⁷ at 2 λ/D. Here we outline the instrument details of MEC including the hardware, firmware, and data reduction and analysis pipeline. We then discuss MEC's current on-sky performance and end with future upgrades and plans

SCExAO/MEC and CHARIS Discovery of a Low Mass, 6 AU-Separation Companion to HIP 109427 using Stochastic Speckle Discrimination and High-Contrast Spectroscopy

We report the direct imaging discovery of a low-mass companion to the nearby accelerating A star, HIP 109427, with the Subaru Coronagraphic Extreme Adaptive Optics (SCExAO) instrument coupled with the MKID Exoplanet Camera (MEC) and CHARIS integral field spectrograph. CHARIS data reduced with reference star PSF subtraction yield 1.1-2.4 $\mu$m spectra. MEC reveals the companion in $Y$ and $J$ band at a comparable signal-to-noise ratio using stochastic speckle discrimination, with no PSF subtraction techniques. Combined with complementary follow-up $L_{\rm p}$ photometry from Keck/NIRC2, the SCExAO data favors a spectral type, effective temperature, and luminosity of M4-M5.5, 3000-3200 $K$, and $\log_{10}(L/L_{\rm \odot}) = -2.28^{+0.04}_{-0.04}$, respectively. Relative astrometry of HIP 109427 B from SCExAO/CHARIS and Keck/NIRC2, and complementary Gaia-Hipparcos absolute astrometry of the primary favor a semimajor axis of $6.55^{+3.0}_{-0.48}$ au, an eccentricity of $0.54^{+0.28}_{-0.15}$, an inclination of $66.7^{+8.5}_{-14}$ degrees, and a dynamical mass of $0.280^{+0.18}_{-0.059}$ $M_{\odot}$. This work shows the potential for extreme AO systems to utilize speckle statistics in addition to widely-used post-processing methods to directly image faint companions to nearby stars near the telescope diffraction limit.Comment: 13 pages, 7 figures, 3 table

Referral pattern of neonates with severe respiratory failure for extracorporeal membrane oxygenation.

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) remains the mainstay of management in neonates with severe but potentially reversible respiratory failure. In the UK, ECMO is available only as a supraregional service at four centres. OBJECTIVE: To explore regional variations in ECMO referrals and neonatal deaths due to severe respiratory failure in England, Wales and Northern Ireland. METHODS: In this retrospective study, data regarding ECMO referrals due to neonatal respiratory failure from January to December 2002 were obtained from the four UK ECMO centres and then subdivided according to the Government Office Regions. Anonymised data regarding neonatal deaths was obtained from Confidential Enquiry into Maternal and Child Health. Neonatal deaths were classified into four groups (group 1: deaths potentially avoidable by ECMO; group 2: deaths where it was unclear whether ECMO would have been of benefit; group 3: neonates not eligible for ECMO; and group 4: data inadequate to classify deaths). RESULTS: There was significant regional variation in the rates of both ECMO referral (0.10 to 0.46 per 1000 live births; (p<0.001)) and neonatal deaths (groups 1 and 2) (0.09 to 0.32 per 1000 live births; (p<0.001)). Regions with high referral rates for ECMO tended towards having higher group 1 plus group 2 neonatal death rates (correlation coefficient = 0.75). CONCLUSION: It is possible that there are significant regional variations in the uptake of ECMO and in neonatal mortality due to severe respiratory failure. A confidential prospective study may further clarify these observations and identify the factors that might lead to these variations